Jung, Unsu <br/><br/>
Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Sep 2006 
 - 905-18 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1083-8791 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2006.05.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD--immunology<br/>Bone Marrow Transplantation--adverse effects<br/>Cell Differentiation--drug effects<br/>Cell Proliferation<br/>Cells, Cultured<br/>Cytokines--immunology<br/>Graft vs Host Disease--drug therapy<br/>Immunosuppressive Agents--pharmacology<br/>Mice<br/>Mice, Inbred BALB C<br/>Sirolimus--pharmacology<br/>T-Lymphocytes--immunology